GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1）

NCT06988592 · clinicaltrials.gov ↗
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fudan University